Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
Postdoctoral researcher (m/f/d) – Medical Department for Hematology, Oncology, and Cell Therapy The Faculty of Medicine is an integral part of the Otto-von-Guericke-University Magdeburg and
-
-dimensional cell cultures are important to enable realistic cell environments for disease modeling and to analyze cell interactions. This position will address the question of how one can develop minimally
-
to identify medically relevant cell types – fast, compact, and affordable. This approach, developed in the Cell Engineering Lab at Helmholtz Munich in collaboration with the Leibniz Institute for Solid State
-
transcriptomic and single-cell analysis of organoid models and patient biopsy samples. What you bring to the table PhD in biology, biochemistry, molecular biology, cell biology, immunology, or related discipline
-
self-correction capabilities of the developing nervous system, focusing on plasticity in cell behavior and cell-cell interactions during regrowth and repair of tissue organization. The work will be
-
biology, hematopoiesis, and immunobiology Excellent teamwork and communication skills Solid experience with flow cytometry and **fluorescence-activated cell sorting (FACS)** FELASA certification and hands
-
dedicated to advancing the understanding of the molecular mechanisms of hematopoiesis, granulopoiesis, and leukemia development. We also develop innovative gene therapy approaches for hematopoietic stem cell
-
users: provide project consultation, training and hands-on support, schedule and prioritize measurements, and ensure timely data delivery Drive method development for single-cell MSI and integration with
-
to apply Strong interest in infection biology and immunology Educational background in one or more of the following subjects: infection biology, immunology, cell biology, microbiology Practical experience in
-
prevention of human diseases (e.g., Li et al., Nature Metabolism, 2024; Ni et al., Cell Metabolism, 2023; Leung et al., Science Translational Medicine, 2022; Seelbinder et al., Nature Communications, 2023